# 2025-11729: California Doc Loses DEA Badge: No More Controlled Drug Handling

2025-11729, Bohdan Olesnicky, M.D.; Decision and Order, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-06-26, effective 2025-07-28; PRIA reads it as touching household money (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-11729
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-11729
- Title: Bohdan Olesnicky, M.D.; Decision and Order
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 27341
- Published: 2025-06-26
- Effective: 2025-07-28
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

California Doc Loses DEA Badge: No More Controlled Drug Handling

## Summary

Dr. Bohdan Olesnicky from California lost his DEA registration because he no longer has permission to handle controlled substances in his state. He didn’t ask for a hearing to challenge this, so the DEA officially revoked his registration starting in 2025. This means he can’t legally prescribe or handle certain drugs anymore, affecting his medical practice and patients.

## Effects PRIA read

- DEA Registration Revoked July 28, 2025: cost, medium. The Drug Enforcement Administration revoked Bohdan Olesnicky, M.D.'s DEA Certificate of Registration No. FO0628391, effective July 28, 2025. Because Dr. Olesnicky surrendered his California medical license on December 5, 2023, he is not authorized to prescribe or handle controlled substances in Cal…
- Pending DEA Applications Denied in California: cost, low. The Order also denies any pending applications by Bohdan Olesnicky, M.D., to renew or modify Certificate of Registration No. FO0628391 and denies any other pending applications for additional DEA registration in California. This denial is part of the same Order that takes effect July 28, 2025.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-11729 on federalregister.gov](https://www.federalregister.gov/documents/2025/06/26/2025-11729/bohdan-olesnicky-md-decision-and-order)
- [2025-11729 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-06-26/pdf/2025-11729.pdf)

## Related
- [Previous: 2025-11496, Agency Information Collection Activities; Proposed Collection; Comment Request;…](https://policyrisk.com/federal-register/2025-11496)
- [Next: 2025-11730, Agency Information Collection Activities; Notice and Request for Comment; Gener…](https://policyrisk.com/federal-register/2025-11730)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-11729 (as of 2026-06-08).
